The top ten pathways are non-alcoholic fatty liver disease, neuroactive ligand–receptor interaction, TNF signaling pathway, proteoglycans in cancer, alcoholic liver disease, chemical carcinogenesis–receptor activation, AGE-RAGE signaling pathway in diabetic complications, Chagas disease, and sphingolipid signaling pathway. Here, RENBP is linked to alcoholic liver diseases.